Welcome to our dedicated page for TEXAS INSTRUMENTS SEC filings (Ticker: TXN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TEXAS INSTRUMENTS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TEXAS INSTRUMENTS's regulatory disclosures and financial reporting.
Knecht Julie C. reported acquisition or exercise transactions in this Form 4 filing.
Texas Instruments Inc. reported that Julie C. Knecht, its VP & Chief Accounting Officer, received an award of 7,154 shares of common stock, described in a footnote as restricted stock units granted under the 2024 Long-Term Incentive Plan at a per-share price of $0.00. Following this equity award, she directly holds 16,294 shares of the company’s common stock.
Texas Instruments reported Q2 2026 results with revenue of $5,463 million, up 23% from a year earlier, and net income of $1,980 million. Diluted EPS rose to $2.14, driven mainly by 26% growth in Analog revenue and 16% growth in Embedded Processing, lifting gross margin to 61.4%.
For the first six months of 2026, revenue reached $10,288 million and net income $3,525 million, with diluted EPS of $3.82. Trailing‑12‑month cash flow from operations was $8,667 million and free cash flow $6,534 million, supported by CHIPS Act incentives and capital spending of $3,312 million.
The company ended June 30, 2026 with total cash and short‑term investments of $7.00 billion and total debt of $14,052 million. It agreed to acquire Silicon Labs for approximately $7.5 billion in cash, backed by a new $5 billion delayed‑draw term loan facility, and continued returning capital via dividends and share repurchases.
Texas Instruments Incorporated reported strong Q2 2026 results, with revenue of $5.46 billion, up 23% from the prior-year quarter, and net income of $1.98 billion. Diluted EPS was $2.14, up 52% from $1.41, including a $0.05 benefit that was not in the company’s original guidance.
Operating profit rose to $2.31 billion, a 48% increase. Over the trailing 12 months, cash flow from operations was $8.7 billion and non-GAAP free cash flow was $6.5 billion, equal to 33.6% of $19,453 million in revenue. TI invested $3.9 billion in R&D and SG&A, $3.3 billion in capital expenditures, and returned $5.8 billion to shareholders through dividends and buybacks.
Analog revenue grew 26% to $4,365 million and Embedded Processing revenue grew 16% to $788 million, while the Other segment declined slightly. Management’s outlook for Q3 2026 is revenue between $5.65 billion and $6.15 billion and EPS between $2.23 and $2.57.
Texas Instruments director Curtis C. Farmer received an award of 85.18 stock units on June 19, 2026 as director compensation. Each stock unit converts into one share of common stock and will be settled after he leaves the board. Following this award, he directly holds 2,911 shares of common stock and 2,143.97 stock units credited under the company’s 2018 Director Compensation Plan, including units from dividend reinvestment.
Texas Instruments director Pamela H. Patsley reported updated equity holdings. She received a grant of 85.18 stock units of Texas Instruments on June 19, 2026 at a reference price of $322.86 per unit under the Texas Instruments 2018 Director Compensation Plan. These stock units convert into common stock on a one-for-one basis and will be settled in common shares after her service as a director ends. Following this grant, she holds 34,487 shares of common stock directly and 65,169.89 stock units credited to her director compensation accounts, including units added through the plans’ dividend reinvestment features.
Texas Instruments Incorporated announced that its board has appointed Julie Knecht as senior vice president and Chief Financial Officer (and Chief Accounting Officer), effective August 1, 2026. She will succeed Rafael Lizardi, who is retiring after 25 years with the company.
The company states that Mr. Lizardi’s retirement is not related to financial or operating results, or to any disagreements about financial reporting or internal controls. In her new role, Ms. Knecht will receive an annual base salary of $700,000 and $2 million in restricted stock units as equity compensation.
TEXAS INSTRUMENTS INC director Martin S. Craighead sold a total of 10,000 shares of Common Stock in open-market transactions. The sales took place on May 28, 2026, in two trades of 357 and 9,643 shares.
The 357-share sale was executed at a weighted average price of $321.0069 per share, and the 9,643-share sale was executed at an average price of $320.4075 per share. A footnote explains that sale prices for one of the trades ranged from $320.00 to $320.9867 and that detailed price breakdowns are available on request. Following these transactions, Craighead continues to hold Common Stock directly.
Texas Instruments Inc. submitted a Form 144 notice dated 05/28/2026 for a proposed sale of 10,000 shares of Common Stock through RBC Capital Markets LLC on the NYSE. The filing lists an aggregate amount of $3,200,000.00 and CUSIP 910092791. The shares were acquired in two open-market purchases: 4,025 shares on 10/25/2018 and 5,975 shares on 01/28/2021.
Texas Instruments senior vice president Ahmad Bahai exercised stock options and sold shares on the same day. On May 14, 2026, he exercised a nonqualified stock option for 5,000 shares of common stock at $110.15 per share, then sold 5,000 shares in an open-market transaction at a weighted average price of $309.1272 per share. The sales occurred in a price range from $308.85 to $309.53. After these transactions, Bahai directly holds 42,519 shares of common stock and 16,534 stock options, which are scheduled to expire on January 25, 2028.
Texas Instruments Sr. Vice President & CFO Rafael R. Lizardi reported an option exercise and related stock sales. He exercised a nonqualified stock option to acquire 47,734 shares of common stock at a strike price of $174.81 per share, then sold 47,734 shares in open-market transactions. The reported sale prices include weighted-average prices of $307.8474, $308.5448, and $309.4487 per share, with footnotes noting price ranges around these levels. After these transactions, he holds 85,485 shares of Texas Instruments common stock directly and 33,994 shares indirectly through a SLAT.